Adsorptive-Mediated Brain Delivery Systems

Author(s): Wei Lu.

Journal Name: Current Pharmaceutical Biotechnology

Volume 13 , Issue 12 , 2012

Become EABM
Become Reviewer

Abstract:

The blood-brain barrier (BBB), which impedes drug penetration into the central nervous system, is composed of specific structures formed by brain capillary endothelial cells and sheathed by astrocytic end-feet through basement membrane. Many brain drug delivery strategies have focused on adsorptive-mediated transcytosis (AMT), which is triggered by electrostatic interaction between cationic molecules and anionic microdomains on the cytoplasm membrane of the brain capillary endothelial cells. AMT-based drug delivery to the brain can be achieved by using cationic proteins and basic oligopeptides such as cell-penetrating peptides as targetors. Large therapeutic molecules such as neuropeptides and proteins or even drug-encapsulated vectors such as liposomes and nanoparticles can be allowed to access brain parenchyma through AMT when conjugated with these cationic targetors. In this review, I briefly discuss adsorptive-mediated brain delivery systems that may provide physiologic-based strategies for enhanced delivery of therapeutic substances through the BBB.

Keywords: Adsorptive-mediated transcytosis (AMT), blood-brain barrier (BBB), cationized protein, nanoparticle, toxicity, central nervous system, endothelial cells, adsorptive-mediated transcytosis (AMT), cationic proteins, neuropeptides, brain capillary endothelial cells (BCECs), astrocytic end-feet, Large therapeutic molecules, blood milieu

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 13
ISSUE: 12
Year: 2012
Page: [2340 - 2348]
Pages: 9
DOI: 10.2174/138920112803341851
Price: $65

Article Metrics

PDF: 24